Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.04 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including other brain neurons; strongest in early primary spermatocytes | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 6020
Sealed predictions
- SKOR2 in dopamine neurons, braak+0.76 (p 0.016) → +0.58 (p 0.102)receipt 6027
Swarm cases
receipt 6027: SKOR2 in dopamine neurons, braak
- power
- full sample +0.68 (p 0.0019, n 18), 95% CI +0.31 to +0.87. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.70 (p 0.0012, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.72 (p 7.0e-4, n 18). not the mix.
- skeptic
- leave-one-out range +0.64 to +0.78, sign flips 0; without severely affected donors +0.68 (p 0.0019, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SKOR2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts